SB465Introduced in the Senate
Classifying xylazine as a schedule III controlled drug.
Introduced by William Gannon, District 23
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Classifying xylazine as a schedule III controlled drug.
Where it stands
Inexpedient to Legislate: Motion Adopted Voice Vote 04/23/2026 House Journal 11 P. 55
April 23, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
Bill history
Introduced 01/07/2026 and Referred to Judiciary; Senate Journal 1
Hearing: 02/10/2026, Room 100, State House, 01:30 pm; Senate Calendar 5A
Committee Report: Ought to Pass with Amendment # 2026-0842s, 03/05/2026; Vote 5-0; Consent Calendar; Senate Calendar 8
Committee Amendment # 2026-0842s, Amendment Adopted, Voice Vote; 03/05/2026; Senate Journal 5
Ought to Pass with Amendment #2026-0842s, Motion Adopted, Voice Vote; OT3rdg; 03/05/2026; Senate Journal 5
Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture House Journal 8 P. 114
Public Hearing: 03/31/2026 01:30 pm GP 153
Full Committee Work Session: 04/07/2026 01:00 pm GP 153
Executive Session: 04/14/2026 01:00 pm GP 153
Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; Regular Calendar)
Minority Committee Report: Ought to Pass
Inexpedient to Legislate: Motion Adopted Voice Vote 04/23/2026 House Journal 11 P. 55
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.